US Surgeons Dodge Disclosure, Kickback Rules Using PODs, Senators Say
This article was originally published in Clinica
Surgeons invested in physician-owned distributorships (PODs) are performing procedures involving implantable devices at a 44% higher rate than non-POD surgeons, and are trying to avoid Sunshine Act requirements, says a May 10 report released by the US Senate Finance Committee. The Senate report takes a particularly dim look at the impact of PODs on spinal surgeons, saying that the rate of spinal surgery grew three times faster for hospitals that purchased from PODs than for hospitals overall.
You may also be interested in...
US Senate Finance Committee leaders say some physicians may have failed to disclose their physician-ownership interests in entities that offer medical supplies to the physician’s own practice, as required under the Physician Payment Sunshine Act. The legislators on March 19 prodded the Health and Human Services' Office of Inspector General (OIG) and the Centers for Medicare and Medicaid Services (CMS) to take a closer look into these arrangements.
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.
The risk of inadvertently growing SARS-CoV-2 virus in cell and gene therapies and possibly infecting patients and workers should be assessed and mitigated, the agency advises.